# Ertapenem

## Ertapenem inj 1gm

| TAH Drug Code      | [IETP](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=IETP)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Treat moderate to severe infections caused by microorganisms susceptible to Ertapenem. Empiric therapy in the following infections before the causative pathogens have been identified: ‧ Complicated intra-abdominal infections, ‧ Complicated skin and skin structure infections ‧ Community-acquired pneumonia ‧ Complicated urinary tract infections, including pyelonephritis ‧ Acute pelvic infections, including postpartum endometritis, septic abortion, and gynecological infections after surgery.                                                                                                                                                                                                                                                                                                   |
| Dosing             | Patients aged 13 years and older: 1 gm IV/IM q24h Children aged 3 months to 12 years: 15 mg/kg IV/IM, divided q12h (max 1 gm/day). [Sanford Guide 2023] Pediatric (age > 28 days): 30 mg/kg/day, divided q12h (max 1 gm/day).                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Contraindications  | Anaphylactic reaction to beta-lactam antibiotics. Hypersensitivity to ertapenem sodium or to any other component of the product or other drugs in the carbapenem class. Hypersensitivity to amide-type local anesthetics due to lidocaine hydrochloride used as a diluent with IM route only.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Adverse Effects    | [Common] Injection site pain (5.5%), Abdominal pain (3.6-4.7%), Constipation (2.3-4%), Diarrhea (6.5-11.7%), Nausea (Adult, 6.4-8.5%; pediatric, >0.5%), Vomiting (2.1-10.2%), Headache (4.4-6.8%), Vaginitis (1.4-3.3%), Infusion reaction (5.4-7.1%) [Serious] Cardiac arrest (>0.1%), Heart failure (>0.1%), Necrosis (>0.1%), Clostridioides difficile infection (>0.1%), Congenital pyloric stenosis (>0.1%), Gastrointestinal hemorrhage (>0.1%), Large intestine anastomotic leak (>0.5%), Anaphylaxis, Hypersensitivity reaction, Cerebrovascular accident (>0.5%), Seizure (>0.1-0.5%), Subdural hemorrhage (>0.1%), Renal impairment (>0.1%), Atelectasis (3.4%), Hemoptysis (>0.1%), Hypoxemia (>0.1%), Pleural effusion (>0.1%), Respiratory distress (>0.1%), Sepsis (>0.1%), Septic shock (>0.1%) |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| More Info          | [UpToDate](https://www.uptodate.com/contents/ertapenem-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |

